The dopamine receptor agonist apomorphine stabilizes neurotoxic α‐synuclein oligomers-Reference-Cited by-同舟云学术

The dopamine receptor agonist apomorphine stabilizes neurotoxic α‐synuclein oligomers

Published:2021-12-29 Issue: Volume: Page:
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:FEBS Letters

Author:

Lima Vanderlei de Araujo¹²,Esquinelato Rodrigo¹,Carmo‐Gonçalves Phelippe¹²^ORCID,Nascimento Lucas Alex do¹,Lee Hudson³^ORCID,Eliezer David³^ORCID,Romão Luciana⁴,Follmer Cristian¹²^ORCID

Affiliation:

1. Department of Physical Chemistry Federal University of Rio de Janeiro Brazil

2. Graduate Program in Chemistry, Institute of Chemistry Federal University of Rio de Janeiro Rio de Janeiro Rio de Janeiro Brazil

3. Department of Biochemistry, Weill Cornell Medical College Cornell University New York NY USA

4. Institute of Biomedical Sciences Federal University of Rio de Janeiro Rio de Janeiro Rio de Janeiro Brazil

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1873-3468.14263

Reference57 articles.

1. The Parkinson's complex: parkinsonism is just the tip of the iceberg;Langston JW;Ann Neurol,2006

2. Parkinson's disease

3. Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr ?-synuclein mutation

4. -Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies

5. α‐Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer;Fauvet B;J Biol Chem,2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of Alpha-Synuclein Conformational Ensemble and Aggregation Pathways by Dopamine and Related Molecules;Frontiers in Bioscience-Landmark;2023-10-26

2. Challenges in Discovering Drugs That Target the Protein–Protein Interactions of Disordered Proteins;International Journal of Molecular Sciences;2022-01-28